Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic for Resistance and Infection Research

Executive Summary: Meropenem trihydrate is a water-soluble, broad-spectrum carbapenem β-lactam antibiotic with potent activity against both gram-negative and gram-positive bacteria, as well as anaerobes (APExBIO product page). It inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. The compound demonstrates low minimum inhibitory concentrations (MIC90) for pathogens such as Escherichia coli and Klebsiella pneumoniae at physiological pH (7.5). Stability and efficacy are influenced by pH, storage temperature, and solvent selection. Recent metabolomics studies, such as Dixon et al. 2025, reveal that carbapenem resistance phenotypes in Enterobacterales involve metabolic pathway alterations, highlighting the importance of Meropenem trihydrate in resistance research (Dixon 2025).

Biological Rationale

Carbapenems, including Meropenem trihydrate, are last-resort antibiotics for multidrug-resistant bacterial infections (Dixon 2025). They exhibit broad-spectrum activity, targeting both gram-negative and gram-positive organisms, and are particularly effective against bacteria producing extended spectrum β-lactamases (ESBLs). Meropenem trihydrate demonstrates efficacy in laboratory models against Enterobacter spp., Citrobacter spp., Proteus mirabilis, Morganella morganii, Streptococcus pyogenes, Viridans group streptococci, and Streptococcus pneumoniae (APExBIO). The prevalence of carbapenem resistance among Enterobacterales is a growing global health concern, necessitating advanced research tools for resistance detection and phenotyping (Dixon 2025).

Mechanism of Action of Meropenem trihydrate

Meropenem trihydrate acts by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), particularly PBP2 and PBP3, disrupting peptidoglycan cross-linking and leading to cell lysis and bacterial death (Related Article: Biochemical Rationale). Unlike some other β-lactam antibiotics, meropenem is stable against many β-lactamases, including ESBLs, but can be hydrolyzed by carbapenemases such as KPC or OXA-48-like enzymes. The efficacy of Meropenem trihydrate is pH-dependent, with increased activity observed at physiological pH (7.5) compared to acidic conditions (pH 5.5) (APExBIO). This pH effect should be considered during assay design.

Evidence & Benchmarks

• Meropenem trihydrate demonstrates low MIC90 values against E. coli and K. pneumoniae at pH 7.5, typically ≤0.25 μg/mL under laboratory conditions (APExBIO).
• In vivo, meropenem trihydrate reduces hemorrhage, fat necrosis, and pancreatic infection in acute necrotizing pancreatitis rat models; effects are enhanced with deferoxamine co-administration (APExBIO).
• Carbapenem resistance in Enterobacterales is mainly mediated by carbapenemase enzymes, with metabolomics studies identifying 21 metabolic biomarkers predictive of resistance phenotype (AUROC ≥0.845) (Dixon 2025).
• Metabolomic pathway enrichment shows altered arginine, purine, and biotin metabolism in carbapenemase-producers, impacting antibiotic efficacy (Dixon 2025).
• Meropenem trihydrate is water-soluble (≥20.7 mg/mL, gentle warming) and DMSO-soluble (≥49.2 mg/mL); insoluble in ethanol (APExBIO).

Applications, Limits & Misconceptions

Meropenem trihydrate is widely used in research on bacterial cell wall synthesis inhibition, resistance phenotyping, and infection models. It is instrumental in metabolomics-driven resistance studies, enabling rapid detection of carbapenemase-producing Enterobacterales (Related Article: Metabolic Resistance). This article extends previous coverage by integrating newly published metabolomics benchmarks and clarifying pH-dependent activity. It is not suitable for direct clinical use, diagnostic applications, or as a substitute for in vivo pharmacokinetic studies.

Common Pitfalls or Misconceptions

• Meropenem trihydrate should not be used for diagnostic or therapeutic purposes in humans or animals (research use only).
• Its activity may be overestimated in vitro if pH or solvent parameters are not controlled; efficacy decreases at acidic pH.
• Stability is compromised at room temperature; solutions must be stored at -20°C and used short-term.
• Carbapenemase-producing organisms can hydrolyze meropenem, resulting in resistance despite in vitro susceptibility.
• It is insoluble in ethanol; incorrect solvent use can lead to assay failure.

Workflow Integration & Parameters

Meropenem trihydrate (SKU B1217, APExBIO) is supplied as a solid. Dissolve in sterile water (≥20.7 mg/mL with gentle warming) or DMSO (≥49.2 mg/mL) for experimental use. Solutions should be freshly prepared, aliquoted, and stored at -20°C. For cell-based assays, adjust media to pH 7.5 for optimal activity. Employ appropriate negative and positive controls, especially in resistance phenotype screens. For metabolomics research, pair Meropenem trihydrate exposure with LC-MS/MS profiling to investigate metabolic shifts in bacterial isolates (Related Article: Metabolome-Guided Breakthroughs; this article updates with new biomarker insights from 2025).

For advanced application scenarios, including cell viability or proliferation assays, scenario-driven guidance is available (Optimizing Antibacterial Assays), but this article clarifies the latest metabolomics-driven approaches and addresses resistance phenotyping.

Conclusion & Outlook

Meropenem trihydrate is a validated, broad-spectrum carbapenem β-lactam antibiotic that inhibits bacterial cell wall synthesis via penicillin-binding protein targeting. Its efficacy and solubility parameters are well-characterized, supporting reproducible research in antimicrobial resistance and infection biology. The emergence of carbapenemase-mediated resistance, elucidated by recent metabolomics studies, underscores the critical role of this compound in experimental resistance profiling and biomarker discovery (Dixon 2025). As resistance phenotyping evolves, integration of Meropenem trihydrate into advanced metabolic and translational workflows will remain essential. For full product details and ordering, see the Meropenem trihydrate (B1217) product page at APExBIO.